Kanebo Has Settled With 17,000+ Consumers For Brightening Product Injuries
This article was originally published in The Rose Sheet
Executive Summary
Kao Corporation subsidiary offered an update June 9 on its probe into reported vitiligo-like symptoms in consumers who used its Rhododenol-containing skin-brightening products, which were recalled from Asian markets in 2013. More than 17,000 affected individuals have accepted settlement agreements to date.
You may also be interested in...
Kao Restructures To Improve Safety, Communications Amid Kanebo Recall
Kanebo Cosmetics’ safety-assessment and customer-relations functions will merge with Kao Corp.’s operations to leverage the parent firm’s resources and state-of-the-art technologies as a recall of Kanebo brightening products goes on. The Japanese firm is accused of dragging its feet in responding to concerns about its whitening ingredient Rhododenol, linked to confirmed vitiligo-like symptoms in 14,000 users.
Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets
As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.